( Log in to your Wikimedia account to use OAuth instead of Quickstatements for updates.)
Author name:
Limit:
Additional SPARQL filters separated by semicolons (eg. for papers on Zika virus, enter wdt:P921 wd:Q202864):
Filter potential authors as well?

Potential publications

50 publications found

Warning: limit reached; process these papers and then reload to see if there are more for this author name string
Click here to create clusters based on exact author strings rather than rougher matches.

Group #1

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer[1]Anne M Noonan, [2]Kristen P Bunch, [3]Jin-Qiu Chen, [4]Michelle A Herrmann, [5]Jung-Min Lee, [6]Elise C Kohn, [7]Ciara C O'Sullivan, [8]Elizabeth Jordan, [9]Nicole Houston, [10]Naoko Takebe, [11]Robert J Kinders, [12]Liang Cao, [13]Cody J Peer, [14]W Douglas Figg, [15]Christina M Annunziata [Full author list]Cancer [missing]DOI: 10.1002/CNCR.29783 [ORCID]
PubMed: 26566079 [ORCID]
platinum [missing]; ovarian cancer [missing]; pharmacodynamics [missing]2015-11-13
CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitiv[1]Jung-Min Lee, [2]Jane B Trepel, [3]Peter L Choyke, [4]Liang Cao, [5]Tristan M Sissung, [6]Nicole Houston, [7]Minshu Yu, [8]William Douglas Figg, Sr., [9]Ismail Baris Turkbey, [10]Seth M Steinberg, [11]Min-Jung Lee, [12]S Percy Ivy, [13]Joyce F Liu, [14]Ursula A. Matulonis, [15]Elise C Kohn [Full author list]Frontiers in Oncology [missing]DOI: 10.3389/FONC.2015.00123 [ORCID]
PubMed: 26082895 [ORCID]
platinum [missing]; ovarian cancer [missing]; biomarker [missing]; olaparib [missing]; phase II clinical trial [missing]2015-06-01
Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial[1]Arun Rajan, [2]Corey A Carter, [3]Arlene Berman, [4]Liang Cao, [5]Ronan J Kelly, [6]Anish Thomas, [7]Sean Khozin, [8]Ariel Lopez Chavez, [9]Isabella Bergagnini, [10]Barbara Scepura, [11]Eva Szabo, [12]Min-Jung Lee, [13]Jane B Trepel, [14]Sarah K Browne, [15]Lindsey B Rosen, [16]Yunkai Yu, [17]Seth M Steinberg, [18]Helen X Chen, [19]Gregory J Riely, [20]Giuseppe Giaccone [Full author list]Lancet Oncology Commission [missing]DOI: 10.1016/S1470-2045(13)70596-5 [ORCID]
PubMed: 24439931 [ORCID]
patient [missing]; multicenter clinical trial [missing]; phase II clinical trial [missing]2014-01-15
Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell[1]Neetu Kalra, [2]Jingli Zhang, [3]Yunkai Yu, [4]Mitchell Ho, [5]Maria Merino, [6]Liang Cao, [7]Raffit Hassan [Full author list]International Journal of Cancer [missing]DOI: 10.1002/IJC.27471 [ORCID]
PubMed: 22323052 [ORCID]
monoclonal antibody [missing]; preproinsulin [missing]2012-04-24
Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma[1]Zhigang Kang, [2]Shi-Yong Sun, [3]Liang Cao [Full author list]ISRN Oncology [missing]DOI: 10.5402/2012/395952 [ORCID]
PubMed: 22577581 [ORCID]
rhabdomyosarcoma [missing]2012-04-17
Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors[1]Giovanna Speranza, [2]Martin E Gutierrez, [3]Shivaani Kummar, [4]John M Strong, [5]Robert J Parker, [6]Jerry Collins, [7]Yunkai Yu, [8]Liang Cao, [9]Anthony J Murgo, [10]James H Doroshow, [11]Alice Chen [Full author list]Cancer Chemotherapy and Pharmacology [missing]DOI: 10.1007/S00280-011-1712-Y [ORCID]
PubMed: 21805353 [ORCID]
2011-07-31
Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors[1]Giuseppe Giaccone, [2]Arun Rajan, [3]Arlene Berman, [4]Ronan J Kelly, [5]Eva Szabo, [6]Ariel Lopez-Chavez, [7]Jane B Trepel, [8]Min-Jung Lee, [9]Liang Cao, [10]Igor Espinoza-Delgado, [11]John Spittler, [12]Patrick J Loehrer [Full author list]Journal of Clinical Oncology [missing]DOI: 10.1200/JCO.2010.32.4467 [ORCID]
PubMed: 21502553 [ORCID]
2011-04-18
Drozitumab, a human antibody to death receptor 5, has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response[1]Zhigang Kang, [2]Jun-Jie Chen, [3]Yunkai Yu, [4]Bo Li, [5]Shi-Yong Sun, [6]Baolin Zhang, [7]Liang Cao [Full author list]Clinical Cancer Research [missing]DOI: 10.1158/1078-0432.CCR-10-2874 [ORCID]
PubMed: 21385927 [ORCID]
antibody [missing]; rhabdomyosarcoma [missing]2011-03-08
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas[1]Shivaani Kummar, [2]Martin E Gutierrez, [3]Alice Chen, [4]Ismail B Turkbey, [5]Deborah Allen, [6]Yvonne R Horneffer, [7]Lamin Juwara, [8]Liang Cao, [9]Yunkai Yu, [10]Yeong Sang Kim, [11]Jane B Trepel, [12]Helen Chen, [13]Peter L Choyke, [14]Giovanni Melillo, [15]Anthony J Murgo, [16]Jerry Collins, [17]James H Doroshow [Full author list]European Journal of Cancer [missing]DOI: 10.1016/J.EJCA.2010.12.016 [ORCID]
PubMed: 21247755 [ORCID]
bevacizumab [missing]; phase I clinical trial [missing]2011-01-17
Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib[1]Ronan J Kelly, [2]Arun Rajan, [3]Jeremy Force, [4]Ariel Lopez-Chavez, [5]Corrine Keen, [6]Liang Cao, [7]Yunkai Yu, [8]Peter L Choyke, [9]Baris Turkbey, [10]Mark Raffeld, [11]Liqiang Xi, [12]Seth M Steinberg, [13]John J Wright, [14]Shivaani Kummar, [15]Martin Gutierrez, [16]Giuseppe Giaccone [Full author list]Clinical Cancer Research [missing]DOI: 10.1158/1078-0432.CCR-10-2331 [ORCID]
PubMed: 21224376 [ORCID]
lung cancer [missing]; magnetic resonance imaging [missing]; biomarker [missing]2011-01-11
Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas[1]Paolo A Zucali, [2]Iacopo Petrini, [3]Elena Lorenzi, [4]Maria Merino, [5]Liang Cao, [6]Luca Di Tommaso, [7]Hye Seung Lee, [8]Matteo Incarbone, [9]Beatriz A Walter, [10]Matteo Simonelli, [11]Massimo Roncalli, [12]Armando Santoro, [13]Giuseppe Giaccone [Full author list]Cancer [missing]DOI: 10.1002/CNCR.25367 [ORCID]
PubMed: 20597130 [ORCID]
phosphorylation [missing]; preproinsulin [missing]2010-10-01
Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody[1]Liang Cao, [2]Yunkai Yu, [3]Isaac Darko, [4]Duane Currier, [5]Linnia H Mayeenuddin, [6]Xiaolin Wan, [7]Chand Khanna, [8]Lee J Helman [Full author list]Cancer Research [missing]DOI: 10.1158/0008-5472.CAN-08-1712 [ORCID]
PubMed: 18829562 [ORCID]
antibody [missing]; rhabdomyosarcoma [missing]; preproinsulin [missing]2008-10-01
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity[1]Nilofer S Azad, [2]Edwin M Posadas, [3]Virginia E Kwitkowski, [4]Seth M Steinberg, [5]Lokesh Jain, [6]Christina M Annunziata, [7]Lori Minasian, [8]Gisele Sarosy, [9]Herbert L Kotz, [10]Ahalya Premkumar, [11]Liang Cao, [12]Deborah McNally, [13]Catherine Chow, [14]Helen X Chen, [15]John J Wright, [16]William Douglas Figg, Sr., [17]Elise C Kohn [Full author list]Journal of Clinical Oncology [missing]DOI: 10.1200/JCO.2007.10.8332 [ORCID]
PubMed: 18669456 [ORCID]
toxicity [missing]; bevacizumab [missing]2008-08-01

Group #2

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Caspase-8 expression is predictive of tumour response to death receptor 5 agonist antibody in Ewing's sarcoma[1]Zhigang Kang, [2]Seth D Goldstein, [3]Yunkai Yu, [4]Paul S Meltzer, [5]David M Loeb, [6]Liang Cao [Full author list]British Journal of Cancer [missing]DOI: 10.1038/BJC.2015.298 [ORCID]
PubMed: 26291055 [ORCID]
2015-08-20
SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma[1]Sai-Wen Tang, [2]Sven Bilke, [3]Liang Cao, [4]Junko Murai, [5]Fabricio Garmus Sousa, [6]Mihoko Yamade, [7]Vinodh Rajapakse, [8]Sudhir Varma, [9]Lee J Helman, [10]Javed Khan, [11]Paul S Meltzer, [12]Yves Pommier [Full author list]Clinical Cancer Research [missing]DOI: 10.1158/1078-0432.CCR-14-2112 [ORCID]
PubMed: 25779942 [ORCID]
2015-03-16
Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications[1]Ramdane Harouaka, [2]Zhigang Kang, [3]Si-Yang Zheng, [4]Liang Cao [Full author list]Pharmacology & Therapeutics [missing]DOI: 10.1016/J.PHARMTHERA.2013.10.004 [ORCID]
PubMed: 24134902 [ORCID]
2013-10-14
Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer[1]Liang Cao, [2]Yunkai Yu, [3]Sven Bilke, [4]Robert L Walker, [5]Linnia H Mayeenuddin, [6]David O Azorsa, [7]Fan Yang, [8]Marbin Pineda, [9]Lee J Helman, [10]Paul S Meltzer [Full author list]Cancer Research [missing]DOI: 10.1158/0008-5472.CAN-10-0582 [ORCID]
PubMed: 20663909 [ORCID]
rhabdomyosarcoma [missing]2010-07-27

Group #3

Matched potential author: Liang Cao - author of 2 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase[1]Yue Ding, [2]Zeyu Cao, [3]Liang Cao, [4]Gang Ding, [5]Zhenzhong Wang, [6]Wei Xiao [Full author list]Scientific Reports [missing]DOI: 10.1038/SREP45723 [ORCID]
PubMed: 28393840 [ORCID]
2017-04-10Liang Cao (Q123604310; 2 items)
Drug discovery of neurodegenerative disease through network pharmacology approach in herbs[1]Zhipeng Ke, [2]Xinzhuang Zhang, [3]Zeyu Cao, [4]Yue Ding, [5]Na Li, [6]Liang Cao, [7]Tuanjie Wang, [8]Chenfeng Zhang, [9]Gang Ding, [10]Zhenzhong Wang, [11]Xiaojie Xu, [12]Wei Xiao [Full author list]Biomedicine and Pharmacotherapy [missing]DOI: 10.1016/J.BIOPHA.2016.01.021 [ORCID]
PubMed: 26898452 [ORCID]
drug discovery [missing]; neurodegeneration [missing]2016-02-02Liang Cao (Q123604310; 2 items)
Luteoloside Acts as 3C Protease Inhibitor of Enterovirus 71 In Vitro[1]Zeyu Cao, [2]Yue Ding, [3]Zhipeng Ke, [4]Liang Cao, [5]Na Li, [6]Gang Ding, [7]Zhenzhong Wang, [8]Wei Xiao [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0148693 [ORCID]
PubMed: 26870944 [ORCID]
2016-01-01Liang Cao (Q123604310; 2 items)
Multiscale Modeling of Drug-induced Effects of ReDuNing Injection on Human Disease: From Drug Molecules to Clinical Symptoms of Disease[1]Fang Luo, [2]Jiangyong Gu, [3]Xinzhuang Zhang, [4]Lirong Chen, [5]Liang Cao, [6]Na Li, [7]Zhenzhong Wang, [8]Wei Xiao, [9]Xiaojie Xu [Full author list]Scientific Reports [missing]DOI: 10.1038/SREP10064 [ORCID]
PubMed: 25973739 [ORCID]
2015-05-14Liang Cao (Q123604310; 2 items)
Study on anti-inflammation and immunoloregulation effect of Guizhi Fuling capsule ingredients using high content screening[1]Yan-ru Wang, [2]Na Li, [3]Liang Cao, [4]Chen-feng Zhang, [5]Tuan-jie Wang, [6]Gang Ding, [7]Zhen-zhong Wang, [8]Wei Xiao [Full author list]Zhongguo Zhongyao Zazhi [missing]PubMed: 26226735 [ORCID]
2015-03-01Liang Cao (Q123604310; 2 items)
Quantitative modeling of dose–response and drug combination based on pathway network[1]Jiangyong Gu, [2]Xinzhuang Zhang, [3]Yimin Ma, [4]Na Li, [5]Fang Luo, [6]Liang Cao, [7]Zhenzhong Wang, [8]Gu Yuan, [9]Lirong Chen, [10]Wei Xiao, [11]Xiaojie Xu [Full author list]Journal of Cheminformatics [missing]DOI: 10.1186/S13321-015-0066-6 [ORCID]
PubMed: 26101547 [ORCID]
2015-01-01Liang Cao (Q123604310; 2 items)
System-level study on synergism and antagonism of active ingredients in traditional Chinese medicine by using molecular imprinting technology[1]Tengfei Chen, [2]Jiangyong Gu, [3]Xinzhuang Zhang, [4]Yimin Ma, [5]Liang Cao, [6]Zhenzhong Wang, [7]Lirong Chen, [8]Xiaojie Xu, [9]Wei Xiao [Full author list]Scientific Reports [missing]DOI: 10.1038/SREP07159 [ORCID]
PubMed: 25418048 [ORCID]
traditional Chinese medicine [missing]2014-11-24
Traditional Chinese herbs as chemical resource library for drug discovery of anti-infective and anti-inflammatory[1]Weixian Ding, [2]Jiangyong Gu, [3]Liang Cao, [4]Na Li, [5]Gang Ding, [6]Zhengzhong Wang, [7]Lirong Chen, [8]Xiaojie Xu, [9]Wei Xiao [Full author list]Journal of Ethnopharmacology [missing]DOI: 10.1016/J.JEP.2014.05.066 [ORCID]
PubMed: 24928828 [ORCID]
drug discovery [missing]2014-06-11Liang Cao (Q123604310; 2 items)

Group #4

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Coexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses[1]Liang Cao, [2]Chunchen Wu, [3]Hui Shi, [4]Zuojiong Gong, [5]Ejuan Zhang, [6]Hui Wang, [7]Kaitao Zhao, [8]Shuhui Liu, [9]Songxia Li, [10]Xiuzhu Gao, [11]Yun Wang, [12]Rongjuan Pei, [13]Mengji Lu, [14]Xinwen Chen [Full author list]Journal of Virology [missing]DOI: 10.1128/JVI.01123-14 [ORCID]
PubMed: 24850745 [ORCID]
Hepatitis B virus [missing]; hepatitis B [missing]; antibody [missing]; viral quasispecies [missing]2014-05-21
Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo[1]Wenbo Zhu, [2]Chunchen Wu, [3]Wanyu Deng, [4]Rongjun Pei, [5]Yun Wang, [6]Liang Cao, [7]Bo Qin, [8]Mengji Lu, [9]Xinwen Chen [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0045146 [ORCID]
PubMed: 23024803 [ORCID]
2012-09-14
Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance[1]Chunchen Wu, [2]Wanyu Deng, [3]Liu Deng, [4]Liang Cao, [5]Bo Qin, [6]Songxia Li, [7]Yun Wang, [8]Rongjuan Pei, [9]Dongliang Yang, [10]Mengji Lu, [11]Xinwen Chen [Full author list]Journal of Virology [missing]DOI: 10.1128/JVI.06353-11 [ORCID]
PubMed: 22301154 [ORCID]
Hepatitis B virus [missing]; hepatitis B [missing]2012-02-01

Group #5

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China[1]Liang Cao, [2]Luke V Selby, [3]Xiang Hu, [4]Yi Zhang, [5]Yelena Y Janjigian, [6]Laura Tang, [7]Daniel G Coit, [8]Murray Brennan, [9]Vivian E Strong [Full author list]Journal of Surgical Oncology [missing]DOI: 10.1002/JSO.24228 [ORCID]
PubMed: 27040753 [ORCID]
United States of America [missing]2016-04-04
Effect of tumor-associated macrophages on gastric cancer stem cell in omental milky spots and lymph node micrometastasis[1]Chi Zhang, [2]Xiang Hu, [3]Xiao-Yu Liu, [4]Pin Liang, [5]Jian Zhang, [6]Liang Cao, [7]Zheng-Lin Wang, [8]Huan-Ran Liu, [9]Xun-Guo Yin, [10]Cheng-Yong Dong, [11]Li-Ming Wang [Full author list]International Journal of Clinical and Experimental Pathology [missing]PubMed: 26823693 [ORCID]
neoplastic stem cells [missing]2015-11-01
The role of the CCL22-CCR4 axis in the metastasis of gastric cancer cells into omental milky spots[1]Liang Cao, [2]Xiang Hu, [3]Jian Zhang, [4]Gang Huang, [5]Yi Zhang [Full author list]Journal of Translational Medicine [missing]DOI: 10.1186/S12967-014-0267-1 [ORCID]
PubMed: 25245466 [ORCID]
2014-09-24

Group #6

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Isolation and characterization of novel genomic and EST-SSR markers in Coreoperca whiteheadi Boulenger and cross-species amplification[1]Changxu Tian, [2]Xufang Liang, [3]Min Yang, [4]Hezi Zheng, [5]Yaqi Dou, [6]Liang Cao [Full author list]International Journal of Molecular Sciences [missing]DOI: 10.3390/IJMS131013203 [ORCID]
PubMed: 23202947 [ORCID]
Coreoperca whiteheadi [missing]2012-10-15
Isolation and characterization of 46 novel polymorphic EST-simple sequence repeats (SSR) markers in two Sinipercine Fishes (Siniperca) and cross-species amplification[1]Chunmei Qu, [2]Xufang Liang, [3]Wei Huang, [4]Liang Cao [Full author list]International Journal of Molecular Sciences [missing]DOI: 10.3390/IJMS13089534 [ORCID]
PubMed: 22949814 [ORCID]
2012-07-30

Group #7

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Cadmium toxicity to embryonic-larval development and survival in red sea bream Pagrus major[1]Liang Cao, [2]Wei Huang, [3]Xiujuan Shan, [4]Zhizhong Xiao, [5]Qiyao Wang, [6]Shuozeng Dou [Full author list]Ecotoxicology and Environmental Safety [missing]DOI: 10.1016/J.ECOENV.2009.06.002 [ORCID]
PubMed: 19573918 [ORCID]
Red Sea [missing]; Pagrus major [missing]2009-07-01
Toxic effects of zinc on the development, growth, and survival of red sea bream Pagrus major embryos and larvae[1]Wei Huang, [2]Liang Cao, [3]Xiujuan Shan, [4]Zhizhong Xiao, [5]Qiyao Wang, [6]Shuozeng Dou [Full author list]Archives of Environmental Contamination and Toxicology [missing]DOI: 10.1007/S00244-009-9348-1 [ORCID]
PubMed: 19504147 [ORCID]
Red Sea [missing]; Pagrus major [missing]2009-06-06

Misc

Matched potential author: Liang Cao - author of 9 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Stretch-activated channel Piezo1 is up-regulated in failure heart and cardiomyocyte stimulated by AngII.[1]Jianlin Liang, [2]Boshui Huang, [3]Guiyi Yuan, [4]Ying Chen, [5]Fasheng Liang, [6]Huayuan Zeng, [7]Shaoxin Zheng, [8]Liang Cao, [9]Dengfeng Geng, [10]Shuxian Zhou [Full author list]American Journal of Translational Research [missing]PubMed: 28670382 [ORCID]
2017-06-15
Correlation of Ventricular Arrhythmogenesis with Neuronal Remodeling of Cardiac Postganglionic Parasympathetic Neurons in the Late Stage of Heart Failure after Myocardial Infarction[1]Dongze Zhang, [2]Huiyin Tu, [3]Chaojun Wang, [4]Liang Cao, [5]Robert L Muelleman, [6]Michael C Wadman, [7]Yu-Long Li [Full author list]Frontiers in Neuroscience [missing]DOI: 10.3389/FNINS.2017.00252 [ORCID]
PubMed: 28533740 [ORCID]
2017-05-08
Toosendanin Exerts an Anti-Cancer Effect in Glioblastoma by Inducing Estrogen Receptor β- and p53-Mediated Apoptosis[1]Liang Cao, [2]Dingding Qu, [3]Huan Wang, [4]Sha Zhang, [5]Chenming Jia, [6]Zixuan Shi, [7]Zongren Wang, [8]Jian Zhang, [9]Jing Ma [Full author list]International Journal of Molecular Sciences [missing]DOI: 10.3390/IJMS17111928 [ORCID]
PubMed: 27869737 [ORCID]
glioblastoma [missing]2016-11-18
Loss of ZG16 is regulated by miR-196a and contributes to stemness and progression of colorectal cancer[1]Xiaobing Chen, [2]Peng Du, [3]Junjun She, [4]Liang Cao, [5]Yingchao Li, [6]Hongping Xia [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.13435 [ORCID]
PubMed: 27880730 [ORCID]
colorectal cancer [missing]2016-11-17
Chemical control over the energy-level alignment in a two-terminal junction[1]Li Yuan, [2]Carlos Franco, [3]Nuria Crivillers, [4]Marta Mas Torrent, [5]Liang Cao, [6]C S Suchand Sangeeth, [7]Concepció Rovira, [8]Jaume Veciana, [9]Christian A Nijhuis [Full author list]Nature Communications [missing]DOI: 10.1038/NCOMMS12066 [ORCID]
PubMed: 27456200 [ORCID]
2016-07-26
Barcoding melting curve analysis for rapid, sensitive, and discriminating authentication of saffron (Crocus sativus L.) from its adulterants[1]Chao Jiang, [2]Liang Cao, [3]Yuan Yuan, [4]Min Chen, [5]Yan Jin, [6]Luqi Huang [Full author list]BioMed Research International [missing]DOI: 10.1155/2014/809037 [ORCID]
PubMed: 25548775 [ORCID]
Crocus sativus [missing]2014-10-30
Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7(th) edition and JCGS 13(th) edition N-classification systems[1]Xiang Hu, [2]Liang Cao, [3]Yi Yu [Full author list]Chinese Journal of Cancer Research [missing]DOI: 10.3978/J.ISSN.1000-9604.2014.10.09 [ORCID]
PubMed: 25400426 [ORCID]
2014-10-01
The effects of epidural/spinal opioids in labour analgesia on neonatal outcomes: a meta-analysis of randomized controlled trials[1]Kai Wang, [2]Liang Cao, [3]Qian Deng, [4]Li-Qiang Sun, [5]Tian-Yu Gu, [6]Jie Song, [7]Dun-Yi Qi [Full author list]Canadian Journal of Anaesthesia [missing]DOI: 10.1007/S12630-014-0185-Y [ORCID]
PubMed: 25011701 [ORCID]
meta-analysis [missing]; epidural anesthesia [missing]2014-07-11
Quantitative femtosecond charge transfer dynamics at organic/electrode interfaces studied by core-hole clock spectroscopy[1]Liang Cao, [2]Xing-Yu Gao, [3]Andrew Wee, [4]Dongchen Qi [Full author list]Advanced Materials [missing]DOI: 10.1002/ADMA.201305414 [ORCID]
PubMed: 24692009 [ORCID]
2014-04-01Liang Cao (Q59824666; 9 items)
Insights into food preference in hybrid F1 of Siniperca chuatsi (♀) × Siniperca scherzeri (♂) mandarin fish through transcriptome analysis[1]Shan He, [2]Xu-Fang Liang, [3]Jian Sun, [4]Ling Li, [5]Ying Yu, [6]Wei Huang, [7]Chun-Mei Qu, [8]Liang Cao, [9]Xiao-Li Bai, [10]Ya-Xiong Tao [Full author list]BMC Genomics [missing]DOI: 10.1186/1471-2164-14-601 [ORCID]
PubMed: 24007400 [ORCID]
Golden mandarin fish [missing]; Mandarin fish [missing]; food preference [missing]2013-09-05
BDNF-mediated migration of cardiac microvascular endothelial cells is impaired during ageing[1]Liang Cao, [2]Liang Zhang, [3]Siyun Chen, [4]Ziqiang Yuan, [5]Shaokun Liu, [6]Xiaotao Shen, [7]Xin Zheng, [8]Xufeng Qi, [9]Kenneth K H Lee, [10]John Yeuk-Hon Chan, [11]Dongqing Cai [Full author list]Journal of Cellular and Molecular Medicine [missing]DOI: 10.1111/J.1582-4934.2012.01621.X [ORCID]
PubMed: 22925160 [ORCID]
endothelium [missing]2012-12-01
Sonic hedgehog promotes autophagy of vascular smooth muscle cells[1]Haijie Li, [2]Jingjing Li, [3]Yuenan Li, [4]Pavneet Singh, [5]Liang Cao, [6]Li-juan Xu, [7]Dong Li, [8]Yuebing Wang, [9]Zhiping Xie, [10]Yu Gui, [11]Xi-Long Zheng [Full author list]American Journal of Physiology Heart and Circulatory Physiology [missing]DOI: 10.1152/AJPHEART.00160.2012 [ORCID]
PubMed: 23023870 [ORCID]
autophagy [missing]2012-09-28
Determination of cnidilin and its two metabolites in rat bile and stool after oral administration by HPLC/electrospray ionization tandem mass spectrometry[1]Hong Zhu, [2]Yanping Ren, [3]Yingguang Sun, [4]Lu Chang, [5]Liang Cao, [6]Huijin Xu, [7]Lantong Zhang [Full author list]Biomedical Chromatography [missing]DOI: 10.1002/BMC.2827 [ORCID]
PubMed: 23019010 [ORCID]
feces [missing]; electrospray ionization [missing]2012-09-27
Aminoflavone, a ligand of the aryl hydrocarbon receptor, inhibits HIF-1alpha expression in an AhR-independent fashion[1]Erika Terzuoli, [2]Maura Puppo, [3]Annamaria Rapisarda, [4]Badarch Uranchimeg, [5]Liang Cao, [6]Angelika M Burger, [7]Marina Ziche, [8]Giovanni Melillo [Full author list]Cancer Research [missing]DOI: 10.1158/0008-5472.CAN-10-1075 [ORCID]
PubMed: 20736373 [ORCID]
2010-08-24
Rapamycin pharmacokinetic and pharmacodynamic relationships in osteosarcoma: a comparative oncology study in dogs[1]Melissa C Paoloni, [2]Christina Mazcko, [3]Elizabeth Fox, [4]Timothy Fan, [5]Susan Lana, [6]William Kisseberth, [7]David M Vail, [8]Kaylee Nuckolls, [9]Tanasa Osborne, [10]Samuel Yalkowsy, [11]Daniel Gustafson, [12]Yunkai Yu, [13]Liang Cao, [14]Chand Khanna [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0011013 [ORCID]
PubMed: 20543980 [ORCID]
sirolimus [missing]; pharmacokinetics [missing]; pharmacodynamics [missing]2010-06-08

Potential author items

NameDescriptionAuthored itemsIdentifiersEmployer(s)
Liang Caoresearcher ORCID ID = 0000-0001-7453-70609ORCID: 0000-0001-7453-7060
University of Science and Technology of China [missing]
Hefei University [missing]
Liang Caoresearcher (ORCID 0000-0003-4452-022X)7ORCID: 0000-0003-4452-022X
Researcher ID: S-3908-2017
Johns Hopkins University [missing]
Zhejiang University [missing]
Liang Caoresearcher ORCID 0000-0001-5974-98152ORCID: 0000-0001-5974-9815
Liang Caoresearcher2
Liang Caoresearcher ORCID 0000-0002-1381-536X1ORCID: 0000-0002-1381-536X
NYU Langone Medical Center [missing]
Liang CaoChinese ichthyologist0
Liang CaoPh.D. University of St. Andrews 20140University of St Andrews [missing]
Other Q number of this author

New Author Item

(if the author you are looking for is not listed above and otherwise not yet in Wikidata)
Author name:
Check ORCID for Liang Cao | Author has ORCID ID:
Check VIAF for Liang Cao | Author has VIAF ID:
Check ResearchGate for Liang Cao | Author has ResearchGate Profile ID:
After creating the new author item, enter the Wikidata ID in the "Other Q number of this author" field above to link to their works.

Author items in these papers

Common author name strings in these papers

Publishing venues for these papers

Topics for these papers

Feedback
Source and documentation (at github)
Wikidata page